NAICONS

NAICONS is a Milan-based biotechnology company specializing in the discovery of novel bioactive natural products, with a primary focus on developing new antibiotics to combat antimicrobial resistance. The company leverages its proprietary microSNaP platform, which integrates genomics and high-throughput screening, to mine its extensive proprietary library of over 45,000 actinomycetes and fungi. NAICONS operates through a dual business model, advancing its own internal pipeline of anti-infective candidates while providing specialized research services and access to its chemical diversity for pharmaceutical and biotech partners. Their expertise spans the entire discovery chain from microbial fermentation and genome mining to advanced natural product chemistry and lead optimization.